• Nuclear cGAS Restricts LINE-1 Retrotransposition

  2026-08-13

  The reference study identifies a nuclear genome-protection function for cGAS: it suppresses LINE-1 retrotransposition by promoting TRIM41-dependent ubiquitination and degradation of ORF2p. Its DNA-damage-responsive CHK2–cGAS–TRIM41–ORF2p axis connects innate immune signaling, transposon control, aging, and tumorigenesis while also defining testable limitations for pharmacological DNA damage response studies.

• 5-Azacytidine: From Demethylation to Dormancy

  2026-08-12

  5-Azacytidine is more than a conventional DNMT inhibitor: its biological impact can range from cytotoxicity in proliferating leukemia cells to durable dormancy reprogramming in disseminated cancer cells. This thought-leadership perspective connects molecular mechanism, experimental design, product strategy, and translational decision-making.

• Recombinant Annexin V for Apoptosis Detection

  2026-08-12

  Brumatti, Sheridan, and Martin established a practical workflow for producing soluble, polyhistidine-tagged recombinant annexin V in Escherichia coli, followed by FITC labeling and apoptotic-cell analysis. The study’s main contribution is methodological: it makes phosphatidylserine exposure assays more accessible for flow cytometry and fluorescence microscopy while clarifying their biological interpretation and limitations.

• Tiamulin (Thiamutilin) Research Workflows

  2026-08-11

  Build more reproducible antibacterial and anti-inflammatory studies with Tiamulin, from strain-level susceptibility testing to poultry, swine, and cell-based models. This guide connects pleuromutilin mechanism, PK/PD planning, and practical troubleshooting without confusing exploratory findings with clinical treatment guidance.

• From TaCKX11-D to Phosphorylation-Aware Translation

  2026-08-11

  The TaCKX11-D wheat study shows how kinase-dependent phosphorylation can connect cytokinin homeostasis with grain development. This thought-leadership article explains how Phosbind Acrylamide can help translational researchers test that connection through antibody-independent, phosphorylation-sensitive SDS-PAGE workflows.

• Bacitracin B1670: Protocol and QC Guide

  2026-08-10

  Bacitracin (SKU B1670) is a peptide antibiotic for controlled antibacterial research involving bacterial cell wall and peptidoglycan synthesis. It is intended for scientific research workflows only and should not be used for diagnostic, clinical, or medical applications.

• Okadaic acid: PP1/PP2A Workflow Guide

  2026-08-09

  Okadaic acid (A4540) supports controlled inhibition of PP2A and PP1 when researchers need to examine phosphorylation-dependent signaling, apoptosis, or phosphatase activity. It should be titrated within the selected model and paired with vehicle, viability, and orthogonal pathway controls rather than treated as a universal apoptosis inducer or broad-spectrum phosphatase blocker.

• From ROS to Cell-Cycle Evidence in CRC

  2026-08-08

  A translational framework for using PI-based DNA-content profiling to connect CGF-driven metabolic stress with cell-cycle arrest and apoptosis in colorectal cancer research.

• ESCO2 Pan-Cancer Analysis and Experimental Validation

  2026-08-07

  Huang and colleagues combine pan-cancer databases, single-cell analysis, immune-infiltration profiling, and cellular experiments to define ESCO2 as a broadly dysregulated cancer-associated factor. Their findings connect ESCO2 with cell-cycle control, CDK1-related signaling, tumor progression, and cancer-cell proliferation, while also highlighting disease-specific prognostic differences.

• Spatially Selective mTORC1 Inhibition Reveals Nuclear Transc

  2026-08-07

  The reference study introduces TerminaTOR, a genetically encoded inhibitor enabling compartment-specific mTORC1 inhibition, uncovering distinct nuclear mTORC1 functions in transcriptional regulation. These findings advance understanding of spatial mTORC1 signaling and offer new strategies for dissecting PI3K/Akt/mTOR pathway dynamics in cellular models.

• 28S rRNA Expansion Segments Drive Multilayered Nucleolar Arc

  2026-08-06

  Wei et al. reveal how multivalent expansion segments (ESs) within 28S rRNA are both necessary and sufficient for assembling multilayered nucleolar structures in eukaryotes. Their findings mechanistically link rRNA sequence evolution to the emergence of complex nucleolar organization, providing a new framework for understanding ribonucleoprotein compartmentalization.

• Mubritinib (TAK 165): Advanced Mitochondrial Targeting in Ca

  2026-08-06

  Explore Mubritinib (TAK 165) as a next-generation mitochondrial inhibitor for acute myeloid leukemia and viral lymphoma research. This article uniquely dissects its mechanism, assay strategies, and cross-domain implications for cancer biology.

• Salinomycin: Quantitative Assay Optimization in HCC Research

  2026-08-05

  Explore how Salinomycin, a polyether ionophore antibiotic, is reshaping hepatocellular carcinoma assay optimization through quantitative, mechanism-driven strategies. This article reveals practical innovations for robust in vitro evaluation, setting it apart from existing guides.

• Lipidomic Reprogramming in Persister Cancer Cells Boosts Fer

  2026-08-05

  The referenced study uncovers mitochondria-dependent lipidomic shifts in drug-tolerant persister cancer cells that heighten ferroptosis sensitivity, illuminating a vulnerability in minimal residual disease. These findings suggest new approaches for targeting chemoresistant cancer subpopulations through metabolic and ferroptosis pathways.

• BX795: Precision PDK1 Inhibitor for Cancer & Immune Assays

  2026-08-04

  BX795 stands out as a potent, selective PDK1 inhibitor enabling reproducible dissection of both cancer signaling and innate immune modulation. This guide delivers advanced workflows, troubleshooting, and reference-driven protocol enhancements to maximize the impact of BX795 in contemporary bench research.

8049 records 8/537 page Previous Next First page 上5页 678910 下5页 Last page